Executive Chair Kevin R Sayer sold 26,759 shares (26.8K) of DXCM at $72.00 on 2026-05-21 under pre-arranged 10b5-1 plan; retains 382,482 shares.
Kevin R Sayer sold 26,759 shares of DEXCOM at $72.00 under a pre-arranged 10b5-1 trading plan, reducing his holdings by 6.5% to 382,482 shares while retaining a substantial position of 382.5K shares. The sale is scheduled per a 10b5-1 plan and therefore not discretionary. His prior trades at DXCM show mixed near-term outcomes (5 prior sales ranging from -6.0% to +20.5% in 30-day returns), and his cross-ticker track record shows an average 90-day return of -10.6% following sells, though the current price of $72.01 is -20.0% from the 52-week high and +17.0% over the past 30 days. The company posted $1,191,900,000.00 in revenue and $199,500,000.00 in net income in the latest quarter, with annual revenue growth of +15.6% and a P/E of 29.88.